
Claudio Soares, MD, PhD, FRCPC, MBA
Professor of Psychiatry
Queen's University

The Menopause Transition: Mood and Anxiety
Wednesday, February 10, 2027
1:30 PM - 2:30 PM
The Menopause Transition: Sleep and Cognition
Wednesday, February 10, 2027
2:30 PM - 3:30 PM
Claudio N Soares MD, PhD, FRCPC, MBA Dr. Soares is a full Professor and former Chair in the Department of Psychiatry at Queen’s University School of Medicine in Kingston, Ontario. He currently serves as the inaugural director of the Centre for Psychedelics Health and Research at Providence Care Hospital & Queen’s University, executive lead for the Canadian Biomarker Integration Network in Depression (CAN-BIND), and regional lead for mental health and addictions at Ontario Health East.
He was recently appointed executive director of the Canadian Menopause Society, after serving as a board member and President of the Menopause Society. Dr. Soares trained as a psychiatrist, completed his Ph.D. on the effects of estrogen for the management of depression in midlife women, and pursued a postdoctoral fellowship in perinatal and reproductive psychiatry at the Massachusetts General Hospital, Harvard Medical School. His research has focused primarily on novel hormonal and non-hormonal options for midlife women experiencing mood and anxiety disorders, vasomotor symptoms, and sleep problems. He is also interested in the use of wearables and digital health technologies to monitor depression and sleep disturbances, and the use of psychedelics for psychiatric disorders and existential distress in late-stage cancer. Dr. Soares is a sought-after educator with more than 240 presentations at national and international meetings and more than 200 peer-reviewed publications in mood disorders and women’s mental health, including in JAMA, Nature, and the American Journal of Psychiatry.
Lecture Summary 1:
This presentation will examine the menopause transition as a period of increased vulnerability to new or recurrent mood and anxiety symptoms in midlife women. The session will review contributing risk factors and strategies that may help reduce psychological distress during this transition. It will also explore evidence-based hormonal and non-hormonal treatment options, with an emphasis on tailoring management to individual patient needs and clinical presentations.
Lecture Summary 2:
This presentation will examine sleep and cognitive changes that can occur during the menopause transition and beyond, with attention to their effects on quality of life and daily functioning. The session will review common clinical patterns and symptom trajectories, as well as how these concerns may intersect with mood changes, vasomotor symptoms, and other menopause-related experiences. It will also explore evidence-based treatment approaches and how an understanding of symptom progression can inform individualized treatment planning.
Goals and Learning Objectives 1:
-
To recognize the menopause transition as a window of vulnerability for anxiety and depressive symptoms in midlife women.
-
To understand the risk factors and preventative strategies to mitigate the risks for psychological distress in menopausal women
-
To apply evidence-based hormonal and non-hormonal treatment options.
Goals and Learning Objectives 2:
-
To recognize patterns of sleep and cognitive changes during the menopause transition.
-
To understand symptom trajectories during the menopause transition and beyond, and why they are important for treatment planning.
-
To apply evidence-based treatment options for these clinical presentations.
Disclosures:
Employment by Ineligible Entity : Canadian Menopause Society
Advisory Board : Eisai, Idorsia, Astellas, Bayer, AbCellera
Grant/Research Support : Eisai, Atai Therapeutics, Ontario Brain Institute, Bayer
Consultant : Eisai, Bayer, Astellas, Idorsia, Astellas, AbCellera
.png)